New Cancer Drug Tracker: Ticilimumab Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

New Cancer Drug Tracker: AP23573 Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report June 2007

Cancer Drug Discoveries: what the future holds: Prostate Cancer Chapter Prostate cancer is the second leading cause of cancer in the US and the third most common cancer ...more

Management Report May 2007

Cancer Drug Discoveries: what the future holds: Non-Small Cell Lung Cancer Chapter Lung cancer affects more than 1.2 million patients a year, with around 1. ...more

Management Report May 2007

Cancer Drug Discoveries: what the future holds FULL REPORT Understand the prospects for this US$24 billion market. ...more

Market Study May 2007

Cancer Drug Discoveries: what the future holds: Colorectal Cancer Chapter Colorectal cancer (CRC) is the third most common cancer in the US in both sexes and accounts for around ...more

Management Report May 2007

Cancer Drug Discoveries: what the future holds: Breast Cancer Chapter Breast cancer is the second most common malignancy in women after skin cancer and accounts for one in ...more

Management Report May 2007

Cancer Drug Discoveries: what the future holds: Renal Cancer Chapter The renal cell carcinoma market was estimated to be worth around US$1 billion in 2006, with a growth rate ...more

Management Report May 2007

New Cancer Drug Tracker: Vectibix Long gone are the days when a drug successfully completing Phase III trials was virtually assured of ...more

Management Report May 2007

Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs Providing…Product forecasts by value 2006/2011; Patent expiry opportunities to 2016; Generic market ...more

Management Report May 2007

Drug Delivery Technology: Revolutionizing Cancer Therapies The burden of disease cancer puts on society is huge. ...more

Management Report May 2007

Insulin Delivery Systems Market Analysis (2007-2010) The report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS provides an updated view ...more

Management Report May 2007

Monoclonal Antibodies: what the future holds After years of anticipation and encouraging responses to pathfinder products, monoclonal antibodies are ...more

Management Report April 2007

Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil An expanding market, a growing population, a regulatory regime supportive of the generics sector, robust ...more

Management Report April 2007

Gene Expression Reagents Markets The study surveys some of the leading companies known to be marketing, manufacturing or developing ...more

Market Study April 2007

The World Medical Markets Fact Book 2007 Thousands of key market facts and statistics at your fingertips! Bringing together a comprehensive range ...more

Market Briefing March 2007